Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening

SJM Hahné, IK Veldhuijzen, L Wiessing, TA Lim… - BMC infectious …, 2013 - Springer
Background Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …

Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers

P Bruggmann - Journal of viral hepatitis, 2012 - Wiley Online Library
With the arrival of simple, efficient and safe interferon‐free treatment regimens, hepatitis C
virus (HCV) therapy will have the potential to be successfully used for the majority of infected …

[HTML][HTML] Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965

BD Smith, RL Morgan, GA Beckett, Y Falck-Ytter… - 2012 - cdc.gov
Hepatitis C virus (HCV) is an increasing cause of morbidity and mortality in the United
States. Many of the 2.7–3.9 million persons living with HCV infection are unaware they are …

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in US primary care settings

DB Rein, BD Smith, JS Wittenborn… - Annals of internal …, 2012 - acpjournals.org
Background: In the United States, hepatitis C virus (HCV) infection is most prevalent among
adults born from 1945 through 1965, and approximately 50% to 75% of infected adults are …

Hepatitis C virus testing of persons born during 1945–1965: recommendations from the Centers for Disease Control and Prevention

BD Smith, RL Morgan, GA Beckett… - Annals of internal …, 2012 - acpjournals.org
Description: The Centers for Disease Control and Prevention (CDC) and a group of
governmental and private sector partners developed these evidence-based …

The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010

I Ditah, F Ditah, P Devaki, O Ewelukwa, C Ditah… - Journal of …, 2014 - Elsevier
Background & Aims In light of the dramatically changing hepatitis C therapeutic landscape,
knowledge of the current burden of HCV infection in the general population of the United …

The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus

DB Rein, JS Wittenborn, BD Smith… - Clinical infectious …, 2015 - academic.oup.com
Background. New hepatitis C virus (HCV) treatments deliver higher cure rates with fewer
contraindications, increasing demand for treatment and healthcare costs. The cost …

[PDF][PDF] Institute of Medicine recommendations for the prevention and control of hepatitis B and C

AE Mitchell, HM Colvin, R Palmer Beasley - Hepatology, 2010 - Wiley Online Library
Despite federal, state, and local public health efforts to prevent and control hepatitis B virus
(HBV) and hepatitis C virus (HCV) infections, these diseases remain serious health …

Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence

PR Spradling, L Rupp, AC Moorman… - Clinical Infectious …, 2012 - academic.oup.com
Background. Little is known about viral hepatitis testing and infection prevalence among
persons in private healthcare organizations (HCOs) in the United States. Methods. To …

[HTML][HTML] HIV infection and risk, prevention, and testing behaviors among injecting drug users—National HIV Behavioral Surveillance System, 20 US cities, 2009

D Broz, C Wejnert, HT Pham, E DiNenno… - MMWR Surveill …, 2014 - cdc.gov
Abstract Problem/Condition: At the end of 2009, an estimated 1,148,200 persons aged≥ 13
years were living with human immunodeficiency virus (HIV) infection in the United States …